Chronic inflammatory diseases and coronary heart disease: Insights from cardiovascular CT

Epidemiological and clinical studies have demonstrated a consistent relationship between increased systemic inflammation and increased risk of cardiovascular events. In chronic inflammatory states, traditional risk factors only partially account for the development of coronary artery disease (CAD) but underestimate total cardiovascular risk likely due to the residual risk of inflammation. Computed coronary tomography angiography (CCTA) may aid in risk stratification by noninvasively capturing early CAD, identifying high risk plaque morphology and quantifying plaque at baseline and in response to treatment. In this review, we focus on reviewing studies on subclinical atherosclerosis by CCTA in individuals with chronic inflammatory conditions including rheumatoid arthritis (RA), systemic lupus erythematous (SLE), human immunodeficiency virus (HIV) infection and psoriasis. We start with a brief review on the role of inflammation in atherosclerosis, highlight the utility of using CCTA to delineate vessel wall and plaque characteristics and discuss combining CCTA with laboratory studies and emerging technologies to complement traditional risk stratification in chronic inflammatory states.     

CCTA技术对冠状动脉狭窄及其钙化斑块的评估

冠状动脉CT血管成像（CCTA）是一种可无创检测冠状动脉粥样硬化性疾病的成像手段,已成为临床筛查及诊断冠心病的首要检查方法。但对于钙化严重的冠状动脉节段,CCTA的特异性及阳性预测值偏低,可导致病人过度治疗,因此限制了CCTA的临床应用。综述钙化斑块伪影对CCTA的影响,并就CCTA对冠状动脉狭窄准确评估的相关技术进展进行分析,以利于临床诊断中提高CCTA对冠状动脉狭窄率的评估。     

Association of high-risk coronary atherosclerosis at CCTA with clinical and circulating biomarkers: Insight from CAPIRE study

BackgroundHigh-risk coronary atherosclerosis features evaluated coronary CT angiography (CCTA) were suggested to have a prognostic role. The present study aimed to evaluate the association of circulating biomarkers with high-risk plaque features assessed by CCTA.MethodsA consecutive cohort of subjects who underwent CCTA because of suspected CAD was screened for inclusion in the CAPIRE study. Based on risk factors (RF) burden patients were defined as having a low clinical risk (0–1 RF with the exclusion of patients with diabetes mellitus as single RF) or an high clinical risk (≥3 RFs). In all patients, measurement of inflammatory biomarkers and CCTA analysis focused on high-risk plaque features were performed. Univariate and multivariate logistic regression analysis were used to evaluate the relationship between clinical and biological variables with CCTA advanced plaque features.Results528 patients were enrolled in CAPIRE study. Older age and male sex appeared to be predictors of qualitative high-risk plaque features and associated with the presence of elevated total, non-calcified and low-attenuation plaque volume. Among circulating biomarkers only hs-CRP was found to be associated with qualitative high-risk plaque features (OR 2.02, p = 0.004 and 2.02, p = 0.012 for LAP and RI > 1.1, respectively) with borderline association with LAP-Vol (OR 1.52, p = 0.076); HbA1c and PTX-3 resulted to be significantly associated with quantitative high-risk plaque features (OR 1.71, p = 0.003 and 1.04, p = 0.002 for LAP-Vol, respectively).ConclusionsOur results support the association between inflammatory biomarkers (hs-CRP, PTX- 3), HbA1c and high-risk atherosclerotic features detected by CCTA. Male sex and older age are significant predictors of high-risk atherosclerosis.     

Prognostic value of coronary atherosclerosis progression evaluated by coronary CT angiography in patients with stable angina

Objectives

To investigate the progression of coronary atherosclerosis burden by coronary CT angiography (CCTA) and to demonstrate its association with the incidence of major adverse cardiac events (MACE).

Methods

We retrospectively studied patients with stable angina who had undergone repeat CCTA due to recurrent or worsening symptoms. Lipid-rich, fibrous, calcified and total plaque burden as well as coronary diameter stenosis were quantitatively analysed. The incidence of MACE during follow-up was determined.

Results

The final cohort consisted of 268 patients (mean age 52.9 ± 9.8 years, 71 % male) with a mean follow-up period of 4.6 ± 0.9 years. Patients with lipid-rich, fibrous, calcified and total plaque burden (%) progression, as well as coronary diameter stenosis (%) progression had a significantly higher incidence of MACE than those without (all p < 0.05). The progression of lipid-rich plaque (HR = 1.601, p = 0.021), total plaque burden (HR = 2.979, p = 0.043) and coronary diameter stenosis (HR = 4.327, p <0.001) were independent predictors of MACE (all p < 0.05).

Conclusions

Patients presenting with recurrent or worsening symptoms associated with coronary artery disease who have coronary atherosclerosis progression on CCTA are at an increased risk of future MACE.

Key Points

? Repeat CCTA can provide information regarding the progression of coronary atherosclerosis. ? Coronary atherosclerosis progression at CCTA is independently associated with MACE. ? CCTA findings could serve as incremental predictors of MACE.

     

颈动脉粥样硬化超声检测和冠状动脉粥样硬化的相关性分析

目的:评价颈动脉粥样硬化对冠状动脉粥样硬化的预测价值,并寻找与颈动脉硬化有关的因素。方法:选择冠状动脉造影后62例患者,行颈动脉超声检查,观察颈动脉内-中膜状况,以所测最大内中膜厚度及斑块发生率为观察指标。同时作血脂生化分析。用SPSS11.0软件包进行统计学分析。结果:冠状动脉造影正常组与病变组之间、病变组之间颈动脉斑块面积、斑块积分、斑块数目、IMT比较有显著差异(P<0.05)。冠状动脉造影结果与颈动脉超声斑块形成结果比较,颈动脉超声的敏感性为82.4(42/51),特异性为72.7%(8/11),总的诊断符合率为82.3%(51/62)。逐步Logistic回归分析,显示年龄、血压、血糖、TG及HDL-ch与IMT有相关性。结论:颈动脉粥样硬化与冠状动脉粥样硬化病变之间有着显著的相关性,提示颈动脉壁内—中膜厚度及斑块能反映冠状动脉粥样硬化程度。     

冠状动脉CT血管成像在引导冠心病介入治疗中的应用及进展

冠状动脉CT血管成像(CCTA)在经皮冠状动脉介入术(PCI)术前可以明确病人是否需要进入导管室检查或治疗,可视化斑块特征及预测PCI术后风险;术中可以提供精确的冠状动脉解剖特征和病变特征,协助选择PCI器材和手术方式;PCI术后利用CCTA可以检测支架内再狭窄。就CCTA在PCI术前、术中和术后的应用价值及研究进展予以综述。     

基于CCTA对胸痛病人高危斑块成分及血流动力学特征的研究

目的 基于冠状动脉CT血管成像（CCTA）研究伴高危斑块的胸痛病人其斑块成分特征及血流动力学特征。方法 回顾性纳入行CCTA且于2个月内行有创冠状动脉造影检查的43例冠心病病人,男30例,女13例,平均年龄（60.8±8.7）岁。依据病人是否存在高危斑块及胸痛将病人分为2组,组1同时存在胸痛和至少1个高危斑块特征（23例）,组2仅有胸痛或高危斑块特征任意一项（20例）。测量斑块成分特征参数[斑块总体积、钙化斑块体积、纤维斑块体积、脂质斑块体积占比（脂质斑块%）、脂质斑块面积、最小管腔面积、偏心指数]和血流动力学特征参数[基于CCTA的血流储备分数（FFR_CT）,斑块近、远端FFR_CT差值（△FFR_CT）]。采用Mann-Whitney U检验或独立样本t检验比较2组间参数的差异。利用约登指数计算斑块成分特征及血流动力学特征判断高危斑块合并胸痛的临界值,采用受试者操作特征（ROC）曲线分析计算其临界值的敏感度、特异度以及曲线下面积（AUC）。结果 组1的脂质斑块%、脂质斑块面积均高于组2（均P<0.05）,FFR_CT值低于组2（P<0.05）,2组间其他斑块成分特征参数及△FFR_CT差异均无统计学意义（均P>0.05）。分析脂质斑块%、脂质斑块面积及FFR_CT 特征参数的诊断能力,FFR_CT的临界值为0.82时的敏感度最高（61%）、特异度最低（85%）,AUC最高（0.80）。结论 采用CCTA分析高危斑块中脂质斑块成分特征并进行FFR_CT测量,可作为评估高危斑块合并胸痛病人的有效辅助手段,为临床治疗决策提供依据。     

Sex differences in computed tomography angiography-derived coronary plaque burden in relation to invasive fractional flow reserve

BackgroundDistinct sex-related differences exist in coronary artery plaque burden and distribution. We aimed to explore sex differences in quantitative plaque burden by coronary CT angiography (CCTA) in relation to ischemia by invasive fractional flow reserve (FFR).MethodsThis post-hoc analysis of the PACIFIC trial included 581 vessels in 203 patients (mean age 58.1 ​± ​8.7 years, 63.5% male) who underwent CCTA and per-vessel invasive FFR. Quantitative assessment of total, calcified, non-calcified, and low-density non-calcified plaque burden were performed using semiautomated software. Significant ischemia was defined as invasive FFR ≤0.8.ResultsThe per-vessel frequency of ischemia was higher in men than women (33.5% vs. 7.5%, p ​< ​0.001). Women had a smaller burden of all plaque subtypes (all p ​< ​0.01). There was no sex difference on total, calcified, or non-calcified plaque burdens in vessels with ischemia; only low-density non-calcified plaque burden was significantly lower in women (beta: -0.183, p ​= ​0.035). The burdens of all plaque subtypes were independently associated with ischemia in both men and women (For total plaque burden (5% increase): Men, OR: 1.15, 95%CI: 1.06–1.24, p ​= ​0.001; Women, OR: 1.96, 95%CI: 1.11–3.46, p ​= ​0.02). No significant interaction existed between sex and total plaque burden for predicting ischemia (interaction p ​= ​0.108). The addition of quantitative plaque burdens to stenosis severity and adverse plaque characteristics improved the discrimination of ischemia in both men and women.ConclusionsIn symptomatic patients with suspected CAD, women have a lower CCTA-derived burden of all plaque subtypes compared to men. Quantitative plaque burden provides independent and incremental predictive value for ischemia, irrespective of sex.     

CT ​Evaluation ​by ​Artificial ​Intelligence ​for ​Atherosclerosis,Stenosis and Vascular ​Morphology ​(CLARIFY): ​A ​Multi-center,international study

BackgroundAtherosclerosis evaluation by coronary computed tomography angiography (CCTA) is promising for coronary artery disease (CAD) risk stratification, but time consuming and requires high expertise. Artificial Intelligence (AI) applied to CCTA for comprehensive CAD assessment may overcome these limitations. We hypothesized AI aided analysis allows for rapid, accurate evaluation of vessel morphology and stenosis.MethodsThis was a multi-site study of 232 patients undergoing CCTA. Studies were analyzed by FDA-cleared software service that performs AI-driven coronary artery segmentation and labeling, lumen and vessel wall determination, plaque quantification and characterization with comparison to ground truth of consensus by three L3 readers. CCTAs were analyzed for: % maximal diameter stenosis, plaque volume and composition, presence of high-risk plaque and Coronary Artery Disease Reporting & Data System (CAD-RADS) category.ResultsAI performance was excellent for accuracy, sensitivity, specificity, positive predictive value and negative predictive value as follows: >70% stenosis: 99.7%, 90.9%, 99.8%, 93.3%, 99.9%, respectively; >50% stenosis: 94.8%, 80.0%, 97.0, 80.0%, 97.0%, respectively. Bland-Altman plots depict agreement between expert reader and AI determined maximal diameter stenosis for per-vessel (mean difference −0.8%; 95% CI 13.8% to −15.3%) and per-patient (mean difference −2.3%; 95% CI 15.8% to −20.4%). L3 and AI agreed within one CAD-RADS category in 228/232 (98.3%) exams per-patient and 923/924 (99.9%) vessels on a per-vessel basis. There was a wide range of atherosclerosis in the coronary artery territories assessed by AI when stratified by CAD-RADS distribution.ConclusionsAI-aided approach to CCTA interpretation determines coronary stenosis and CAD-RADS category in close agreement with consensus of L3 expert readers. There was a wide range of atherosclerosis identified through AI.     

How accurate is atherosclerosis imaging by coronary computed tomography angiography?

Invasive coronary plaque imaging such as intravascular ultrasound and optical coherence tomography has been widely used to observe culprit or non-culprit coronary atherosclerosis, as well as optimize stent sizing, apposition and deployment. Coronary computed tomographic angiography (CTA) is non-invasively available to assess coronary artery disease (CAD) and has become an appropriate strategy to evaluate patients with suspected CAD. Given recent technologies, semi-automated plaque software is available to identify coronary plaque stenosis, volume and characteristics and potentially allows to be used for the assessment of more details of plaque information, progression and future risk as a surrogate tool of the invasive imaging modalities. This review article aims to focus on various evidence in coronary plaque imaging by coronary CTA and describes how accurate coronary CTA can classify coronary atherosclerosis.     

64层CT评价冠脉粥样斑块性质与狭窄程度的相关性

目的：探讨64层CT评价冠状动脉粥样硬化斑块性质与冠脉狭窄程度之间的相关性。方法：36例疑诊为冠心病患者行64层冠状动脉CT血管成像（CCTA）及冠状动脉血管造影（CAG）检查,以CAG为标准评价CCTA诊断冠脉狭窄程度的准确性,并诊断冠状动脉粥样硬化斑块性质,分析其与经CAG确诊的冠脉狭窄程度之间有无统计学意义。结果：36例患者中共检出105个斑块。冠脉轻度狭窄以钙化斑块引起为主,冠脉中度狭窄和重度狭窄以混合斑块引起为主。CCTA诊断冠状动脉钙化斑块与管腔轻度狭窄、混合斑块与中重度管腔狭窄存在相关性。结论：64层CCTA可在诊断冠脉狭窄的同时无创性评价斑块性质,可及时发现冠脉中脂质成分丰富的斑块,以便尽早及时给予临床干预,可降低急性冠脉综合征发生率。     

动态容积320排冠状动脉CT血管成像诊断冠状动脉疾病的意义

目的：研究320排动态容积冠状动脉CT成像（CCTA）诊断冠状动脉疾病（CAD）的可行性。方法：5961例临床诊断CAD的患者进行CCTA检查,其中186例接受常规X线冠状动脉造影术（CAG）,对照分析其检查结果。1490例接受CCTA检查的健康查体者作为对照。结果：成像质量均在I～III级,无呼吸伪影图像。在186例CAD患者中,CCTA诊断冠状动脉狭窄（狭窄度≥50％）的敏感性为96．72％,特异性98．95％,阳性预测值95．16％,阴性预测值99．30％,准确度98．56％。结论：320排动态容积CT冠状动脉成像图像清晰,对诊断CAD具有重要的临床价值。     

第二代双源CT前门控冠状动脉成像与冠状动脉造影比较的初步研究

目的:探讨第二代双源CT前门控冠状动脉成像(CTCA)对冠状动脉狭窄病变的诊断价值。方法:连续44例同期行第二代双源CT前门控CTCA(其中前门控序列扫描35例,前门控大螺距螺旋扫描9例)及选择性冠状动脉造影(SCA)检查的患者,按冠脉病变狭窄程度分为:无狭窄;轻度狭窄(狭窄≤50%);中度狭窄(狭窄50%～75%);重度狭窄(狭窄≥75%);闭塞(狭窄100%),将中度及中度以上狭窄定义为有意义狭窄。以SCA为金标准,分析第二代双源CT前门控CTCA诊断冠状动脉狭窄的敏感性、特异性、阳性和阴性预测值及准确度,同时计算第二代双源CT前门控CTCA的辐射剂量。结果:44例患者冠脉直径2mm以上的节段共570个,其中12段图像质量较差,无法评估,可评估节段占97.89%。第二代双源CT前门控CTCA按冠脉节段计算,诊断冠状动脉狭窄的敏感度、特异度、阳性和阴性预测值、准确度分别为90.18%、93.05%、76.52%、97.42%、92.47%,诊断冠状动脉有意义狭窄的敏感度、特异度、阳性和阴性预测值、准确度分别为90.14%、95.69%、75.29%、98.52%、94.98%。第二代双源CT前门控CTCA与SCA比较对冠状动脉狭窄评价的差异无统计学意义(χ2=2.10,P>0.05),对冠状动脉有意义狭窄评价的差异无统计学意义(χ2=1.46,P>0.05)。第二代双源CT前门控CT-CA的平均辐射剂量为(3.36±1.59)mSv,其中前门控序列扫描的平均辐射剂量为(3.99±1.18)mSv,前门控大螺距螺旋扫描的平均辐射剂量为(1.11±0.44)mSv。结论:第二代双源CT前门控成像对诊断冠状动脉狭窄的准确度稍低于SCA,但其阴性预测值较高,同时其辐射剂量较低,可作为临床冠心病筛查的无创性检查手段。     

The evolving role of coronary CT angiography in Acute Coronary Syndromes

In the United States, non-obstructive coronary disease has been on the rise, and each year, nearly one million adults suffer myocardial infarction, 70% of which are non-ST-segment elevation myocardial infarction (NSTEMI). In addition, approximately 15% of patients suffering NSTEMI will have subsequent readmission for a recurrent acute coronary syndrome (ACS). While invasive angiography remains the standard of care in the diagnostic and therapeutic approach to these patients, these methods have limitations that include procedural complications, uncertain specificity in diagnosis of the culprit lesion in patients with multi-vessel coronary artery disease (CAD), and challenges in following coronary disease over time. The role of coronary computed tomography angiography (CCTA) for evaluating patients with both stable and acute chest pain has seen a paramount upshift in the last decade. This paper reviews the established role of CCTA for the rapid exclusion of obstructive plaque in troponin negative acute chest pain, while exploring opportunities to address challenges in the current approach to evaluating NSTEMI.     

What is the role of calcium scoring in the age of coronary computed tomographic angiography?

Non-contrast-enhanced CT for coronary artery calcification (CAC) as a marker of coronary atherosclerosis has been studied extensively in the primary prevention setting. With rapidly evolving multidetector CT technology, contrast-enhanced coronary CT angiography (CCTA) has emerged as the non-invasive method of choice for detailed imaging of the coronary tree. In this review, we systematically evaluate the role of CAC testing in the age of CCTA in both asymptomatic and symptomatic patients, across varying levels of risk. Although the role of CAC testing is well established in asymptomatic subjects, its use in evaluating those with stable symptoms that represent possible obstructive coronary artery disease is controversial. Nevertheless, available data suggest that in low-to-intermediate risk symptomatic patients, CAC scanning may serve as an appropriate gatekeeper to further testing with either CCTA (if no or only mild CAC present) versus functional imaging or invasive coronary angiography (when moderate or severe CAC present). Given the strong short-term prognostic value of CAC?=?0, studies are needed to further evaluate the role of CAC scanning in low-risk patients with acute chest pain presenting to the emergency room.     

基于冠状动脉CT血管成像的斑块定量分析及其与心肌缺血损伤的相关性研究

目的使用第三代双源冠状动脉CT血管成像(CCTA)及斑块定量技术分析冠状动脉斑块成分特征,探讨其与心肌缺血的相关性,并评价各项定量特征在评估心肌缺血中的价值。方法回顾性分析2018年6月至2019年9月于山东省立医院行CCTA和冠状动脉造影(ICA)检查的742例初诊冠心病患者,纳入ICA证实存在单支病变局限性狭窄的患者109例。将患者根据心肌酶升高伴心脏室壁运动不良和心肌酶及心脏室壁运动正常分为心肌缺血性损伤组(n=75)和心肌无缺血损伤组(n=34)。测量斑块的特征参数,包括斑块长度、斑块总体积、钙化斑块体积、脂质斑块体积、纤维斑块体积、斑块负荷、最小管腔面积、最大面积狭窄率(MAS%)、重塑指数、偏心指数、"餐巾纸环"征、斑点状钙化。采用卡方检验、Mann-Whitney U非参数检验、两独立样本t检验、多因素logistic回归及DeLong检验进行统计学分析。结果在冠状动脉管腔狭窄定量指标方面,心肌缺血损伤组的MAS%为85.00%(80.00%,92.00%),心肌无缺血损伤组的MAS%为63.00%(60.00%,65.00%),两组间差异具有统计学意义(Z=-4.32,P=0.001)。在斑块成分定量指标方面,心肌缺血损伤组的斑块总体积(TPV)、斑块负荷(TPB)、纤维成分斑块体积(FPV)、脂质成分斑块体积(LPV)、脂质成分斑块占比(LPR)分别为150.13(104.44,202.20)mm^3、75.67%±9.90%、95.73(66.57,134.23)mm^3、32.18(18.93,54.55)mm^3、25.13%±13.71%,心肌无缺血损伤组的相应指标分别为109.94(79.39,121.67)mm^3、65.37%±6.94%、67.35(57.67,90.11)mm^3、16.64(13.26,24.73)mm^3、18.44%±7.09%,两组间差异具有统计学意义(Z=-2.59,P=0.010;t=3.11,P=0.003;Z=-2.16,P=0.031;Z=-2.18,P=0.029;t=2.19,P=0.037)。Logistic回归分析显示,MAS%(OR=1.55,P=0.021)是心肌缺血性损伤的独立预测因子。MAS%、LPV、LPR、TPV、TPB、FPV的ROC曲线下面积分别为0.84、0.82、0.77、0.72、0.74、0.67,差异均具有统计学意义(P<0.05)。结论在CCTA斑块定量分析中,MAS%、TPV、TPB、FPV、LPV、LPR是影响心肌缺血性损伤的主要因素;MAS%是心肌缺血性损伤的独立预测因子;且MAS%及LPV诊断心肌缺血的准确性更高。     

Calcium score,coronary artery disease extent and severity,and clinical outcomes among low Framingham risk patients with low vs high lifetime risk: Results from the CONFIRM registry

Background

Short-term risk scores, such as the Framingham risk score (FRS), frequently classify younger patients as low risk despite the presence of uncontrolled cardiovascular risk factors. Among patients with low FRS, estimation of lifetime risk is associated with significant differences in coronary arterial calcium scores (CACS); however, the relationship of lifetime risk to coronary atherosclerosis on coronary CT angiography (CCTA) and prognosis has not been studied.

Methods and Results

We evaluated asymptomatic 20-60-year-old patients without diabetes or known coronary artery disease (CAD) within an international CT registry who underwent ≥64-slice CCTA. Patients with low FRS (<10%) were stratified as low (<39%) or high (≥39%) lifetime CAD risk, and compared for the presence and severity of CAD and prognosis for death, myocardial infarction, and late coronary revascularization (>90 days post CCTA). 1,863 patients of mean age of 47 years were included, with 48% of the low FRS patients at high lifetime risk. Median follow-up was 2.0 years. Comparing low-to-high lifetime risk, respectively, the prevalence of any CAD was 32% vs 41% (P < .001) and ≥50% stenosis was 7.4% vs 9.6% (P = .09). For those with CAD, subjects at low vs high lifetime risk had lower CACS (median 12 [IQR 0-94] vs 38 [IQR 0.05-144], P = .02) and less purely calcified plaque, 35% vs 45% (P < .001). Prognosis did not differ due to low number of events.

Conclusion

Assessment of lifetime risk among patients at low FRS identified those with the increase in CAD prevalence and severity and a higher proportion of calcified plaque.     

基于冠状动脉CT血管成像定量钙化负荷的可行性研究

目的 探讨冠状动脉CT血管成像（CCTA）一站式计算冠状动脉钙化积分（CCTA-CS）和体积积分（CCTA-VS）的可行性,并分析其与心电门控CT平扫测得标准积分（CACS、VS）的相关性。 方法 本研究回顾性连续纳入1 075例受试者,男447例,女628例,平均年龄（56.79±9.49）岁。全部受试者均行包括门控CT平扫和CCTA的常规冠状动脉CT检查,测量CACS、VS、CCTA-CS和CCTA-VS。选择CACS与CCTA-CS均不为0的影像数据进行分析。采用组内相关系数（ICC）评估2名观察者间及观察者内测量CCTA-CS和CCTA-VS的一致性。采用线性相关分析与Bland-Altman检验分析CCTA与门控CT平扫所测评分的相关性与一致性。根据CACS对受试者进行心血管病危险度分层,并采用Kruskal-Wallis H检验比较多组间的CCTA-CS与CCTA-VS。采用二元Logistic回归分析影响钙化积分的危险因素。采用独立样本t检验比较CCTA和常规冠状动脉CT检查的有效辐射剂量（ED）。 结果 CACS和CCTA-CS不为0的受试者共437例。2名观察者间和观察者内测量的CCTA-CS和CCTA-VS的一致性均较好（均ICC>0.960）。CCTA-CS与CACS、CCTA-VS与VS均呈较好的正相关（r²=0.98、0.96,均P<0.05）。Bland-Altman检验结果显示CCTA与门控CT平扫所测评分间的一致性较高。不同危险分层病人的CCTA-CS和CCTA-VS差异均有统计学意义（均P<0.05）。Logistic回归分析显示高血压、糖尿病、高脂血症、吸烟史、脑血管病均为CACS、CCTA-CS的危险因素。CCTA检查的ED低于常规冠状动脉CT检查,Flash扫描可减少21.2%,Sequence扫描可减少18.6%。 结论 CCTA一站式测量可以精确定量钙化,测得的CCTA-CS、CCTA-VS与标准积分有较好的相关性,且能有效降低辐射剂量。